0576-88813233
产品描述:
K858是一种新型的、有效的Eg5抑制剂,抑制Eg5的ATPase活性,IC50为1.3 μM,对Eg5的选择性是对其他驱动蛋白的至少150倍。
中文别名:
N-(4-乙酰基-4,5-二氢-5-甲基-5-苯基-1,3,4-噻二唑-2-基)乙酰胺
物化属性:
密度:1.27
折射率:1.627
颜色:white to off-white
[1]. Nakai R, et al. K858, a novel inhibitor of mitotic kinesin Eg5 and antitumor agent, induces cell death in cancer cells. Cancer Res. 2009 May 1;69(9):3901-9.
[2]. De Iuliis F, et al. The kinesin Eg5 inhibitor K858 induces apoptosis but also survivin-related chemoresistance in breast cancer cells. Invest New Drugs. 2016 Aug;34(4):399-406.
版权所有 Copyright(C) 2018-2024 台州市科瑞生物技术有限公司